Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis.
about
Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease.Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.Chlamydia pneumoniae in atherosclerosis.Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.Chlamydia pneumoniae and other risk factors for atherosclerosis.Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.Microorganisms in the aetiology of atherosclerosis.Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?Incidence of first ever stroke during Hajj ceremony.Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control studyRespiratory disease and cardiovascular morbidityEvaluation of the level of antibodies against Chlamydophila (Chlamydia) pneumoniae in post-surgery heart ischaemia patients and their clinical conditions - a six-year studyPersistent infection and vascular disease: a systematic review.Determinants of lumbar artery occlusion among patients with sciatica: a three-year follow-up with magnetic resonance angiography.Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages.Pathogenesis of atherosclerosis: A multifactorial process.Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.Infection-induced coronary dysfunction and systemic inflammation in piglets are dampened in hypercholesterolemic milieu.Chlamydia pneumoniae infection is associated with elevated body mass index in young men.The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women.Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism.Burden of infection and fat mass in healthy middle-aged men.Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis.Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile.Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis.Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNAChlamydia pneumoniae-reactive T lymphocytes in abdominal aortic aneurysms: the smoking gun?[Persistence of Chlamydia pneumoniae in human arteriosclerotic plaque substance. Evidence and consequences]Winter mortality and its causes.Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial TheoryHelicobacter pylori seropositivity and atherosclerosis risk factors.Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels.Periodontitis decreases the antiatherogenic potency of high density lipoprotein.The relationship between serum lipids and periodontitis in elderly non-smokers.Serum high-density lipoprotein cholesterol level associated with the extent of periodontal inflammation in type 1 diabetic subjects.Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein.
P2860
Q33222091-18C2C045-2072-4352-B5C3-D6ECA84335A5Q33726287-0122AEDB-D8A2-4AD8-83ED-6BFA3DD81239Q33890410-870CBB48-CE49-4D0C-B8D1-71AF148F8F1EQ33935003-1AA08256-79D1-4223-9CDC-D18F63F5B923Q33935014-724FE7BA-8A7F-4E4D-84C5-CF81C0DAA74EQ33987842-A0ABECB5-CF11-4AFC-B756-FA380B937A8CQ34065709-593B7EC2-FED4-457D-ADEE-ED621D145F54Q34316462-0B2ACFFD-A499-4187-9EC0-F17D6A66E64CQ34522585-A51157A2-36E2-4FBA-A6D0-06B2F82533FCQ35121619-E555437B-B03C-45B1-BDB6-FBCCD094AAD9Q35504161-4BB6C934-9297-49AB-8D0A-C3BDB8B0E754Q35762026-91AA8E19-2A88-4770-A820-5433DED98C7AQ36181163-2B4346DA-C9E6-45B6-9005-A1C24E0485B3Q36371970-7290DD6E-8457-4819-9952-6153A29DF2B9Q36979142-C6225157-6DC2-4EBE-B931-DBA7EB2B1794Q37276377-024037C6-7AD2-482F-9FEB-39FD58E7A8E8Q37835683-7FBBDE30-3871-4C13-9BBF-6D3D374C658AQ37851309-A35C236B-E332-464D-8E3C-B8016ACC1C73Q37853903-6B9E8DB4-2072-438D-9060-BACAE1D242DFQ37858277-04FA6A3C-2159-4EA3-B7EA-597502603ACDQ37858375-2703BA5E-0143-47B5-98B9-E230D8952B07Q37860560-C132BAE2-10AD-4EBE-9CFF-6BFAB0001D07Q37861388-0995A8FD-AC0C-461F-B8F3-401EA7300973Q37864512-28581929-EC74-4673-B77D-0F84610C0D2EQ37865648-9BB90043-4417-4283-A7CF-067E7D28D28FQ37876599-4043FA7E-A384-4724-A5E0-D27F7295146DQ37876764-60649EA7-112D-4099-B15A-2A7E5B11D44CQ37878309-E9505FE0-9960-41BF-AEA7-E65CDD35F9E3Q37880723-F8BA718E-B593-4BF7-8836-6E26C888E65FQ39125936-06154344-858F-4C07-86A7-4478C9F3FF13Q39365197-DEC3296A-38CB-4FD2-A204-1F7D8BF05AB9Q40432710-70EC48EA-F021-40E4-A3AC-A6D77FACB83BQ44003835-6B2F7821-9D6A-451D-87D7-F7F87F56C601Q44586596-F23C2227-F304-4015-A0D2-F458131C659BQ46030538-8A44DD1F-F2F0-4070-983E-9A2BD0F06C91Q53838129-55F1BA52-6318-44C8-BD73-5B43C2E1677BQ54968783-5DA11516-30C2-46B9-A1C0-2F48933C1082
P2860
Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Chronic Chlamydia pneumoniae i ...... sk factor for atherosclerosis.
@en
Chronic Chlamydia pneumoniae i ...... sk factor for atherosclerosis.
@nl
type
label
Chronic Chlamydia pneumoniae i ...... sk factor for atherosclerosis.
@en
Chronic Chlamydia pneumoniae i ...... sk factor for atherosclerosis.
@nl
prefLabel
Chronic Chlamydia pneumoniae i ...... sk factor for atherosclerosis.
@en
Chronic Chlamydia pneumoniae i ...... sk factor for atherosclerosis.
@nl
P2093
P1476
Chronic Chlamydia pneumoniae i ...... sk factor for atherosclerosis.
@en
P2093
P304
P356
10.1161/01.ATV.17.11.2910
P407
P577
1997-11-01T00:00:00Z